Clinical evidence for Alma platforms

Home Clinical evidence

Clinical evidence for Alma platforms

Alma platforms are supported by peer-reviewed clinical research. Explore published studies by platform, with access to each publication, to review the clinical evidence and inform your technology choices.

51 peer-reviewed studies9 platformsAccess to every publication

All studies are also available in our Clinical Resources library, searchable by platform and indication.

Reading the clinical evidence. Each entry lists the publication year, authors and journal. Where research was conducted on an earlier Alma platform sharing the same core technology, this is noted in the section summary. Published outcomes reflect controlled study conditions; clinical results vary with patient selection, treatment parameters and operator experience, which is why every Alma Lasers Australia clinic receives protocol-based training.

Alma Soprano (Titanium SE, ICE Platinum, ICE)laser hair removal

Twelve peer-reviewed studies on triple-wavelength and 810 nm diode technology, including five randomised or controlled trials comparing low-fluence in-motion treatment with high-fluence single-pass and Nd:YAG approaches, alongside efficacy and safety data in skin types IV to V.

12 studiesView platform

Harmony XL Pro and Alma Harmonyskin platform

Clinical evidence across the Harmony applicators, including Dye-VL narrowband light, ClearLift Q-switched Nd:YAG and 1540 nm fractional erbium:glass, covering vascular lesions, photodamage, skin texture, acne scarring and tattoo removal.

12 studiesView platform

Alma HybridCO₂ and 1570 nm resurfacing

Clinical and histological evidence for combined CO₂ and 1570 nm treatment, including periorbital rejuvenation and sequential application. Alma Hybrid, as supplied by Alma Lasers Australia, is included in the ARTG (321320).

3 studiesARTG 321320View platform

Alma Pixel CO₂fractional CO₂ resurfacing

Clinical evidence for fractional CO₂ resurfacing, acne scarring, keloid management and laser-assisted drug delivery. Alma Pixel CO₂ is included in the ARTG (323941).

5 studiesARTG 323941View platform

Alma PrimeXbody contouring

Clinical evidence for pulsed ultrasound combined with unipolar radiofrequency for non-invasive circumference reduction and body contouring.

2 studiesView platform

Accent Primeradiofrequency and ultrasound

Clinical evidence for radiofrequency and ultrasound, covering lipolysis, skin tightening, cellulite, pore size and non-surgical periorbital tightening.

5 studiesView platform

Fractional microplasma (Alma Opus)

Fractional microplasma radiofrequency research on scarring, striae and post-burn pigmentation. Several studies were conducted on Alma's earlier microplasma platform, whose core technology is carried forward in Alma Opus.

5 studiesView platform

Alma QQ-switched Nd:YAG

Clinical evidence for Q-switched 1064 nm treatment of post-surgical scarring, hyperpigmentation in skin types IV to V, active acne and non-ablative rejuvenation.

4 studiesView platform

Alma Duolow-intensity shockwave for erectile dysfunction

Three systematic reviews and meta-analyses of low-intensity extracorporeal shockwave therapy, the technology class to which Alma Duo belongs.

3 studiesView platform

Building Australian clinical evidence

Alma Lasers Australia is developing a library of Australian case series in partnership with clinics that share anonymised before-and-after outcomes, reflecting local skin types and sun exposure. To contribute your clinic’s results or request the full text of any study, contact your Alma representative.

Contact our team

Clinical evidence FAQs

Do these studies apply to the devices supplied in Australia?

Most studies were conducted on current Alma platforms. Where research used an earlier platform sharing the same core technology, such as the microplasma studies, this is noted in the relevant section. All devices supplied by Alma Lasers Australia are current models included in the ARTG.

Why do some studies have small sample sizes?

Aesthetic device research typically progresses from pilot and split-face studies to larger clinical series and systematic reviews. This library includes both, reflecting the full evidence base. Your Alma representative can recommend the papers most relevant to your indications.

Is Australian clinical data available?

Australian case series are currently being collected with participating clinics. Alma Academy sessions also share Australian practitioner experience across local skin types.

Further reading

The technology behind the clinical evidence

Loading...